|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
|
US5436146A
(en)
|
1989-09-07 |
1995-07-25 |
The Trustees Of Princeton University |
Helper-free stocks of recombinant adeno-associated virus vectors
|
|
US6268213B1
(en)
|
1992-06-03 |
2001-07-31 |
Richard Jude Samulski |
Adeno-associated virus vector and cis-acting regulatory and promoter elements capable of expressing at least one gene and method of using same for gene therapy
|
|
US5869305A
(en)
|
1992-12-04 |
1999-02-09 |
The University Of Pittsburgh |
Recombinant viral vector system
|
|
US5478745A
(en)
|
1992-12-04 |
1995-12-26 |
University Of Pittsburgh |
Recombinant viral vector system
|
|
EP0682717A4
(en)
|
1993-02-05 |
1997-04-23 |
Laporte Group Australia |
ANTI-FOAMING COMPOSITE FOR DAIRY.
|
|
US5869337A
(en)
|
1993-02-12 |
1999-02-09 |
President And Fellows Of Harvard College |
Regulated transcription of targeted genes and other biological events
|
|
US5834266A
(en)
|
1993-02-12 |
1998-11-10 |
President & Fellows Of Harvard College |
Regulated apoptosis
|
|
US6972193B1
(en)
|
1993-02-12 |
2005-12-06 |
Board Of Trustees Of Leland Stanford Junior University |
Regulated transcription of targeted genes and other biological events
|
|
US6140120A
(en)
|
1993-02-12 |
2000-10-31 |
Board Of Trustees Of Leland Stanford Jr. University |
Regulated transcription of targeted genes and other biological events
|
|
US20020173474A1
(en)
|
1993-02-12 |
2002-11-21 |
President And Fellows Of Harvard College |
Methods & materials involving dimerization-mediated regulation of biological events
|
|
US5830462A
(en)
|
1993-02-12 |
1998-11-03 |
President & Fellows Of Harvard College |
Regulated transcription of targeted genes and other biological events
|
|
HUT73101A
(en)
|
1993-02-12 |
1996-06-28 |
Harvard College |
Method for regulating transcription of targeted genes and other biological events
|
|
US6150137A
(en)
|
1994-05-27 |
2000-11-21 |
Ariad Pharmaceuticals, Inc. |
Immunosuppressant target proteins
|
|
US6476200B1
(en)
|
1994-06-27 |
2002-11-05 |
The Johns Hopkins University |
Mammalian proteins that bind to FKBP12 in a rapamycin-dependent fashion
|
|
US6204059B1
(en)
|
1994-06-30 |
2001-03-20 |
University Of Pittsburgh |
AAV capsid vehicles for molecular transfer
|
|
US6150527A
(en)
|
1994-08-18 |
2000-11-21 |
Ariad Pharmaceuticals, Inc. |
Synthetic multimerizing agents
|
|
US6133456A
(en)
|
1994-08-18 |
2000-10-17 |
Ariad Gene Therapeutics, Inc. |
Synthetic multimerizing agents
|
|
ES2245781T3
(es)
|
1994-08-18 |
2006-01-16 |
Ariad Gene Therapeutics, Inc. |
Nuevos agentes de multimerizacion.
|
|
US5786464C1
(en)
|
1994-09-19 |
2012-04-24 |
Gen Hospital Corp |
Overexpression of mammalian and viral proteins
|
|
ATE544776T1
(de)
|
1994-12-29 |
2012-02-15 |
Massachusetts Inst Technology |
Chimäre dna-bindeproteine
|
|
US6326166B1
(en)
|
1995-12-29 |
2001-12-04 |
Massachusetts Institute Of Technology |
Chimeric DNA-binding proteins
|
|
US6166197A
(en)
|
1995-03-06 |
2000-12-26 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds having pyrimidine nucleotide (S) with 2'and 5 substitutions
|
|
US6187757B1
(en)
|
1995-06-07 |
2001-02-13 |
Ariad Pharmaceuticals, Inc. |
Regulation of biological events using novel compounds
|
|
US5811524A
(en)
|
1995-06-07 |
1998-09-22 |
Idec Pharmaceuticals Corporation |
Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
|
|
US6506379B1
(en)
|
1995-06-07 |
2003-01-14 |
Ariad Gene Therapeutics, Inc. |
Intramuscular delivery of recombinant AAV
|
|
US5741683A
(en)
|
1995-06-07 |
1998-04-21 |
The Research Foundation Of State University Of New York |
In vitro packaging of adeno-associated virus DNA
|
|
KR19990022651A
(ko)
|
1995-06-07 |
1999-03-25 |
데이비드 엘. 버스테인 |
생물학적 사건에 대한 라파마이신 기재 조절방법
|
|
US6093570A
(en)
|
1995-06-07 |
2000-07-25 |
The University Of North Carolina At Chapel Hill |
Helper virus-free AAV production
|
|
WO1997031898A1
(en)
|
1996-02-28 |
1997-09-04 |
Ariad Gene Therapeutics, Inc. |
Synthetic derivatives of rapamycin as multimerizing agents for chimeric proteins with immunophilin-derived domains
|
|
US6723531B2
(en)
|
1996-04-05 |
2004-04-20 |
The Salk Institute For Biological Studies |
Method for modulating expression of exogenous genes in mammalian systems, and products related thereto
|
|
WO1998002441A2
(en)
|
1996-07-12 |
1998-01-22 |
Ariad Pharmaceuticals, Inc. |
Non immunosuppressive antifungal rapalogs
|
|
EP2327797B1
(en)
|
1997-04-01 |
2015-11-25 |
Illumina Cambridge Limited |
Method of nucleic acid sequencing
|
|
EP1007637B1
(en)
|
1997-04-14 |
2004-06-30 |
Cell Genesys, Inc. |
Methods for increasing the efficiency of recombinant aav product
|
|
US6479653B1
(en)
|
1997-08-26 |
2002-11-12 |
Ariad Gene Therapeutics, Inc. |
Compositions and method for regulation of transcription
|
|
JP2003524368A
(ja)
|
1997-08-26 |
2003-08-19 |
アリアド ジーン セラピューティクス インコーポレイテッド |
ニ量化ドメイン、三量化ドメインまたは四量化ドメインおよび補足的非相同転写活性化ドメイン、転写抑制ドメイン、ｄｎａ結合ドメインまたはリガンド結合ドメインを含む融合蛋白
|
|
US6015709A
(en)
|
1997-08-26 |
2000-01-18 |
Ariad Pharmaceuticals, Inc. |
Transcriptional activators, and compositions and uses related thereto
|
|
IL134643A0
(en)
|
1997-08-27 |
2001-04-30 |
Ariad Gene Therapeutics Inc |
Chimeric transcriptional activators and compositions and uses related thereto
|
|
WO1999036553A2
(en)
|
1998-01-15 |
1999-07-22 |
Ariad Gene Therapeutics, Inc. |
Regulation of biological events using multimeric chimeric proteins
|
|
JP2002503667A
(ja)
|
1998-02-13 |
2002-02-05 |
プレジデント・アンド・フェローズ・オブ・ハーバード・カレッジ |
新規な二量体化剤、その製造および使用
|
|
US6984635B1
(en)
|
1998-02-13 |
2006-01-10 |
Board Of Trustees Of The Leland Stanford Jr. University |
Dimerizing agents, their production and use
|
|
US6333318B1
(en)
|
1998-05-14 |
2001-12-25 |
The Salk Institute For Biological Studies |
Formulations useful for modulating expression of exogenous genes in mammalian systems, and products related thereto
|
|
US6146874A
(en)
|
1998-05-27 |
2000-11-14 |
University Of Florida |
Method of preparing recombinant adeno-associated virus compositions
|
|
US6258603B1
(en)
|
1998-06-17 |
2001-07-10 |
Rohm And Haas Company |
Ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
|
|
US6221349B1
(en)
|
1998-10-20 |
2001-04-24 |
Avigen, Inc. |
Adeno-associated vectors for expression of factor VIII by target cells
|
|
US6200560B1
(en)
|
1998-10-20 |
2001-03-13 |
Avigen, Inc. |
Adeno-associated virus vectors for expression of factor VIII by target cells
|
|
US7109317B1
(en)
|
1998-11-06 |
2006-09-19 |
President And Fellows Of Harvard College |
FK506-based regulation of biological events
|
|
EP1135468B1
(en)
|
1998-11-10 |
2010-01-06 |
University Of North Carolina At Chapel Hill |
Virus vectors and methods of making and administering the same
|
|
US6596535B1
(en)
|
1999-08-09 |
2003-07-22 |
Targeted Genetics Corporation |
Metabolically activated recombinant viral vectors and methods for the preparation and use
|
|
US7067526B1
(en)
|
1999-08-24 |
2006-06-27 |
Ariad Gene Therapeutics, Inc. |
28-epirapalogs
|
|
IL147803A0
(en)
|
1999-08-24 |
2002-08-14 |
Ariad Gene Therapeutics Inc |
28-epirapalogs
|
|
US6780639B1
(en)
|
1999-08-24 |
2004-08-24 |
Universite Libre De Bruxelles |
Antibiotic inducible/repressible genetic construct for gene therapy or gene immunization
|
|
JP3961737B2
(ja)
|
2000-02-29 |
2007-08-22 |
株式会社小糸製作所 |
車両用灯具およびその製造方法
|
|
US20040033600A1
(en)
|
2001-03-21 |
2004-02-19 |
Palli Subba Reddy |
Ecdysone receptor-based inducible gene expression system
|
|
WO2001070816A2
(en)
|
2000-03-22 |
2001-09-27 |
Rohm And Haas Company |
Ecdysone receptor-based inducible gene expression system
|
|
AU6814901A
(en)
|
2000-06-01 |
2001-12-11 |
Univ North Carolina |
Methods and compounds for controlled release of recombinant parvovirus vectors
|
|
US8105825B2
(en)
|
2000-10-03 |
2012-01-31 |
Intrexon Corporation |
Multiple inducible gene regulation system
|
|
ES2385598T3
(es)
|
2001-02-20 |
2012-07-27 |
Intrexon Corporation |
Sistema novedoso de expresión génica inducible basado en el receptor de ecdisona/receptor X retinoide de invertebrado
|
|
CA2438119C
(en)
|
2001-02-20 |
2014-12-16 |
Rheogene Holdings, Inc. |
Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system
|
|
AU2002306550B2
(en)
|
2001-02-20 |
2007-10-25 |
Intrexon Corporation |
Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
|
EP1534738B1
(en)
|
2001-02-20 |
2012-06-20 |
Intrexon Corporation |
Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
|
IL158487A0
(en)
|
2001-05-18 |
2004-05-12 |
Wisconsin Alumni Res Found |
Method for the synthesis of dna sequences
|
|
CN103589692B
(zh)
|
2001-11-13 |
2018-07-24 |
宾夕法尼亚大学托管会 |
检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法
|
|
DK2359869T3
(en)
|
2001-12-17 |
2019-04-15 |
Univ Pennsylvania |
Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof
|
|
AU2003274397A1
(en)
|
2002-06-05 |
2003-12-22 |
University Of Florida |
Production of pseudotyped recombinant aav virions
|
|
US8005620B2
(en)
|
2003-08-01 |
2011-08-23 |
Dna Twopointo Inc. |
Systems and methods for biopolymer engineering
|
|
WO2005012877A2
(en)
|
2003-08-01 |
2005-02-10 |
Dna Twopointo Inc. |
Systems and methods for antibody engineering
|
|
EP1668143B1
(en)
|
2003-09-30 |
2013-03-20 |
The Trustees of The University of Pennsylvania |
Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor
|
|
US20060246079A1
(en)
|
2003-11-14 |
2006-11-02 |
Morrow Phillip R |
Neutralizing human antibodies to anthrax toxin
|
|
US7935510B2
(en)
|
2004-04-30 |
2011-05-03 |
Intrexon Corporation |
Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
|
US7838657B2
(en)
|
2004-12-03 |
2010-11-23 |
University Of Massachusetts |
Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibitory sequences
|
|
DE23193606T1
(de)
|
2005-04-07 |
2024-02-15 |
The Trustees Of The University Of Pennsylvania |
Verfahren zur erhöhung der funktion eines aav-vektors
|
|
JP4495210B2
(ja)
|
2005-06-09 |
2010-06-30 |
パナソニック株式会社 |
振幅誤差補償装置及び直交度誤差補償装置
|
|
PT2548560E
(pt)
|
2005-06-23 |
2015-09-22 |
Isis Pharmaceuticals Inc |
Composições e métodos de modulação da excisão-união de smn2
|
|
US8877187B2
(en)
|
2005-07-25 |
2014-11-04 |
Avianax, Llc |
Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases
|
|
US7588772B2
(en)
|
2006-03-30 |
2009-09-15 |
Board Of Trustees Of The Leland Stamford Junior University |
AAV capsid library and AAV capsid proteins
|
|
CN101528916B
(zh)
*
|
2006-04-28 |
2013-09-04 |
宾夕法尼亚大学托管会 |
规模可调的aav生产方法
|
|
HUE044182T2
(hu)
|
2006-06-07 |
2019-10-28 |
Genzyme Corp |
Génterápia amiotrófiás laterális szklerózis és más gerincvelõ-rendellenességek kezelésére
|
|
JP5675109B2
(ja)
|
2007-02-20 |
2015-02-25 |
アナプティスバイオ インコーポレイティッド |
ライブラリーの生成方法及びその使用
|
|
CN102046654A
(zh)
|
2007-03-13 |
2011-05-04 |
胡马斯有限公司 |
针对甲型流感病毒h5n1株系的抗体
|
|
WO2008124934A1
(en)
|
2007-04-17 |
2008-10-23 |
National Research Council Of Canada |
Constructs for enhancement of gene expression in muscle
|
|
US7879326B2
(en)
|
2007-06-15 |
2011-02-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Human neutralizing monoclonal antibodies to H5N1 influenza A virus
|
|
US7863425B2
(en)
|
2007-09-26 |
2011-01-04 |
Cornell University |
Compositions and methods for inhibiting Yersinia pestis infection
|
|
AU2008321016B2
(en)
|
2007-11-12 |
2013-03-28 |
Theraclone Sciences, Inc. |
Compositions and methods for the therapy and diagnosis of influenza
|
|
EP3524619A1
(en)
|
2007-12-06 |
2019-08-14 |
Dana-Farber Cancer Institute, Inc. |
Antibodies against influenza virus and methods of use thereof
|
|
ITTO20080204A1
(it)
|
2008-03-17 |
2009-09-18 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali atti a reagire con una pluralita di sottotipi del virus influenzale a
|
|
CA2719201A1
(en)
|
2008-03-28 |
2009-10-01 |
Sea Lane Biotechnologies, Llc. |
Neutralizing molecules to viral antigens
|
|
ITTO20080398A1
(it)
|
2008-05-27 |
2009-11-28 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali aventi proprieta' di cross-neutralizzazione omosubtipica per virus influenzali di tipo a sottotipo h1
|
|
WO2010044921A2
(en)
|
2008-06-03 |
2010-04-22 |
Vaxin Inc. |
Intranasal administration of receptor-binding ligands or genes encoding such ligands as a therapeutic regimen for mitigating infections caused by respiratory pathogens
|
|
US8871207B2
(en)
|
2008-07-25 |
2014-10-28 |
Humabs, LLC |
Neutralizing anti-influenza A virus antibodies and uses thereof
|
|
CA2731686C
(en)
|
2008-07-25 |
2020-04-07 |
Institute For Research In Biomedicine |
Neutralizing anti-influenza a virus antibodies and uses thereof
|
|
WO2010053572A2
(en)
|
2008-11-07 |
2010-05-14 |
Massachusetts Institute Of Technology |
Aminoalcohol lipidoids and uses thereof
|
|
US8211631B2
(en)
|
2008-12-18 |
2012-07-03 |
Wisconsin Alumni Research Foundation |
In vitro model of spinal muscular atrophy
|
|
WO2010071832A1
(en)
|
2008-12-19 |
2010-06-24 |
Nationwide Children's Hospital |
Delivery of polynucleotides across the blood brain barrier using recombinant aav9
|
|
KR101790354B1
(ko)
|
2009-05-11 |
2017-10-25 |
얀센 백신스 앤드 프리벤션 비.브이. |
인플루엔자 바이러스 ｈ3ｎ2를 중화시킬 수 있는 인간 결합 분자 및 그것의 용도
|
|
US8734809B2
(en)
|
2009-05-28 |
2014-05-27 |
University Of Massachusetts |
AAV's and uses thereof
|
|
IT1395961B1
(it)
|
2009-06-01 |
2012-11-02 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali come medicamento per il trattamento terapeutico e/o profilattico delle infezioni da virus influenzale a (h1n1) di origine suina (s-oiv)
|
|
KR20220084437A
(ko)
|
2009-06-17 |
2022-06-21 |
바이오젠 엠에이 인코포레이티드 |
대상에게서 ｓｍｎ２ 스플라이싱을 조정하기 위한 조성물 및 방법
|
|
JP5745511B2
(ja)
|
2009-06-25 |
2015-07-08 |
メディミューン，エルエルシー |
ブタインフルエンザヘマグルチニン変異体
|
|
US8598331B2
(en)
|
2009-09-28 |
2013-12-03 |
The University Of British Columbia |
CLDN5 mini-promoters
|
|
US9315825B2
(en)
|
2010-03-29 |
2016-04-19 |
The Trustees Of The University Of Pennsylvania |
Pharmacologically induced transgene ablation system
|
|
WO2011126808A2
(en)
|
2010-03-29 |
2011-10-13 |
The Trustees Of The University Of Pennsylvania |
Pharmacologically induced transgene ablation system
|
|
US8927514B2
(en)
|
2010-04-30 |
2015-01-06 |
City Of Hope |
Recombinant adeno-associated vectors for targeted treatment
|
|
JP6091435B2
(ja)
|
2011-02-22 |
2017-03-08 |
カリフォルニア インスティチュート オブ テクノロジー |
アデノ随伴ウイルス（ａａｖ）ベクターを用いたタンパク質の送達
|
|
EP3699286A1
(en)
|
2011-04-20 |
2020-08-26 |
The Trustees of the University of Pennsylvania |
Regimens and compositions for aav-mediated passive immunization of airborne pathogens
|
|
WO2012145759A2
(en)
|
2011-04-21 |
2012-10-26 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University |
Methods of protein production and compositions thereof
|
|
KR20220025112A
(ko)
|
2011-06-08 |
2022-03-03 |
샤이어 휴먼 지네틱 테라피즈 인크. |
Mrna 전달을 위한 지질 나노입자 조성물 및 방법
|
|
FR2977562B1
(fr)
|
2011-07-06 |
2016-12-23 |
Gaztransport Et Technigaz |
Cuve etanche et thermiquement isolante integree dans une structure porteuse
|
|
EP2731967B1
(en)
|
2011-07-14 |
2016-10-12 |
Janssen Vaccines & Prevention B.V. |
Human binding molecules capable of neutralizing influenza a viruses of phylogenetic group 1 and phylogenetic group 2 and influenza b viruses
|
|
CN103842601A
(zh)
|
2011-09-29 |
2014-06-04 |
艾利丹尼森公司 |
增加营销机会的防盗安全装置
|
|
JP6170507B2
(ja)
|
2012-01-31 |
2017-07-26 |
国立大学法人大阪大学 |
Ｂ型インフルエンザウイルスに対する広範な保護を与えるヒトモノクローナル抗体及びその使用方法
|
|
MX360056B
(es)
|
2012-03-08 |
2018-10-19 |
Janssen Vaccines & Prevention Bv |
Moléculas de unión humanas que pueden unirse a los virus de la influenza b y neutralizarlos, y sus usos.
|
|
WO2013155222A2
(en)
|
2012-04-10 |
2013-10-17 |
The Regents Of The University Of California |
Brain-specific enhancers for cell-based therapy
|
|
EA037448B1
(ru)
|
2012-06-08 |
2021-03-30 |
Этрис Гмбх |
Способ доставки в легкие терапевтической мрнк с pei и фармацевтическая композиция
|
|
CN104704123A
(zh)
|
2012-06-21 |
2015-06-10 |
肌肉学研究协会 |
基因治疗载体的广泛的基因递送
|
|
EP4678239A3
(en)
|
2012-08-01 |
2026-04-08 |
Ikaika Therapeutics, Inc. |
Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (ltbp4)
|
|
US9719106B2
(en)
|
2013-04-29 |
2017-08-01 |
The Trustees Of The University Of Pennsylvania |
Tissue preferential codon modified expression cassettes, vectors containing same, and uses thereof
|
|
BR112015027336A2
(pt)
|
2013-05-01 |
2017-09-26 |
Genzyme Corp |
composições e processos para tratamento de atrofia muscular espinhal
|
|
US20170183396A1
(en)
|
2014-02-19 |
2017-06-29 |
Jody Berry |
Ebola monoclonal antibodies
|
|
WO2015164723A1
(en)
|
2014-04-25 |
2015-10-29 |
The Trustees Of The University Of Pennsylvania |
Methods and compositions for treating metastatic breast cancer and other cancers in the brain
|
|
US10746742B2
(en)
*
|
2014-04-25 |
2020-08-18 |
Oregon Health & Science University |
Methods of viral neutralizing antibody epitope mapping
|
|
US11555059B2
(en)
|
2014-04-25 |
2023-01-17 |
The Trustees Of The University Of Pennsylvania |
LDLR variants and their use in compositions for reducing cholesterol levels
|
|
CR20160519A
(es)
|
2014-05-13 |
2017-01-27 |
The Trustees Of The Univ Of Pennysylvania |
Composiciones que comprenden avv que expresa constructos de anticuerpos duales y sus usos
|
|
WO2016049230A1
(en)
*
|
2014-09-24 |
2016-03-31 |
City Of Hope |
Adeno-associated virus vector variants for high efficiency genome editing and methods thereof
|
|
WO2016054598A2
(en)
|
2014-10-03 |
2016-04-07 |
Massachusetts Institute Of Technology |
Antibodies that bind ebola glycoprotein and uses thereof
|
|
CA2975655C
(en)
|
2015-02-05 |
2023-09-19 |
Janssen Vaccines & Prevention B.V. |
Binding molecules directed against influenza hemagglutinin and uses thereof
|
|
WO2016200543A2
(en)
|
2015-05-13 |
2016-12-15 |
The Trustees Of The University Of Pennsylvania |
Aav-mediated expression of anti-inluenza antibodies and methods of use thereof
|
|
US11135313B2
(en)
|
2015-10-28 |
2021-10-05 |
The Trustees Of The University Of Pennsylvania |
Intrathecal administration of adeno-associated-viral vectors for gene therapy
|
|
US11015174B2
(en)
|
2015-12-11 |
2021-05-25 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for AAV8
|
|
WO2017100674A1
(en)
|
2015-12-11 |
2017-06-15 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aav1
|
|
EP3387138B2
(en)
|
2015-12-11 |
2026-05-27 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aav9
|
|
EP3992283A1
(en)
|
2015-12-11 |
2022-05-04 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aavrh10
|
|
WO2017106326A1
(en)
|
2015-12-14 |
2017-06-22 |
The Trustees Of The University Of Pennsylvania |
Aav-anti pcsk9 antibody constructs and uses thereof
|
|
AU2016370630B2
(en)
|
2015-12-14 |
2023-04-13 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated viral vectors useful in treatment of spinal muscular atropy
|
|
WO2017106244A1
(en)
|
2015-12-14 |
2017-06-22 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for regulatable antibody expression
|
|
MA43968A
(fr)
|
2016-02-03 |
2018-12-12 |
Univ Pennsylvania |
Thérapie génique pour traiter la mucopolysaccharidose de type i
|
|
HUE053747T2
(hu)
*
|
2016-08-15 |
2021-07-28 |
Genzyme Corp |
Eljárások AAV kimutatására
|
|
WO2018057916A1
(en)
|
2016-09-24 |
2018-03-29 |
The Trustees Of The University Of Pennsylvania |
Novel humanized anti-ebola antibodies useful in preventing ebola infections
|
|
JOP20190200A1
(ar)
|
2017-02-28 |
2019-08-27 |
Univ Pennsylvania |
تركيبات نافعة في معالجة ضمور العضل النخاعي
|
|
RS65241B1
(sr)
|
2017-02-28 |
2024-03-29 |
Univ Pennsylvania |
Vektor adeno-asociranih virusa (aav) iz podgrupe f i njegove upotrebe
|
|
TW201837170A
(zh)
|
2017-02-28 |
2018-10-16 |
賓州大學委員會 |
新穎ａａｖ媒介的流感疫苗
|